NextBio

Help

A type of familial lipid metabolism disorder characterized by a variable pattern of elevated plasma CHOLESTEROL and/or TRIGLYCERIDES. Multiple genes on different chromosomes may be involved, such as the major late transcription factor (UPSTREAM STIMULATORY FACTORS) on CHROMOSOME 1.

View Complete Description




Individual Studies
  • OMIM - Hyperlipidemia

    Homo sapiens Homo sapiens | Mutations/Phenotypic   Mutations/Phenotypic

    This study contains curated human phenotype data extracted from OMIM. Additional computational processing and curation of the phenotype data was performed to further organize and group data from related phenotypes into unifying disease categories.

    Source: NextBio Library/Mutation and Phenotypic data

View All Individual Studies

Thought leaders and organizations working on research involving familial combined hyperlipidemia.

  • Jacqueline de Graaf
  • Anton F H Stalenhoef
  • Aldons J Lusis
  • Päivi Pajukanta
  • Tjerk W A de Bruin
  • National Heart, Lung, and Blood Institute (NHLBI)
  • University Hospital, Basel, Switzerland
  • Daiichi Sankyo Inc.
  • Takeda Global Research & Development Center, Inc.
  • Sanofi-Aventis
  • University of California
  • Radboud University Nijmegen Medical Centre
  • Imperial College London
  • University Medical Center Nijmegen
  • University of California, Los Angeles

Community

Help for Community
View All NextBio Users | 1 person
  • No NextBio groups were found for “familial combined hyperlipidemia”.
    Be the first to start a group and share your interests with others within the NextBio community.